(HRTX) Heron Therapeuti - Performance -25.9% in 12m
HRTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-67.01%
#96 in Peer-Group
Rel. Strength
18.36%
#6284 in Stock-Universe
Total Return 12m
-25.93%
#92 in Peer-Group
Total Return 5y
-86.04%
#103 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 3.67 USD |
| 52 Week Low | 1.06 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 80.00 |
| Buy/Sell Signal +-5 | 0.83 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: HRTX (-25.9%) vs XBI (-9.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.02% | 69.7% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-10.4% | -7.09% | 151% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.42% | -1.57% | 39.4% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.65% | 30.3% | -1.81% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.39% | -9.49% | -0.73% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
10.5% | 38.7% | -6.49% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.82% | 50.2% | -13.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.95% | 29.1% | 18.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: HRTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HRTX
| Total Return (including Dividends) | HRTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 3.77% | 0.53% | 3.75% |
| 3 Months | 24.29% | 21.37% | 25.32% |
| 12 Months | -25.93% | -9.11% | 13.11% |
| 5 Years | -86.04% | -25.99% | 109.78% |
| Trend Score (consistency of price movement) | HRTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 67% | -5.7% | 80.3% |
| 3 Months | 20.4% | 79.4% | 97.2% |
| 12 Months | 4.6% | -86.9% | 45.4% |
| 5 Years | -83.8% | -52.2% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th74.50 | 3.23% | 0.02% |
| 3 Month | %th50.50 | 2.41% | -0.82% |
| 12 Month | %th54.50 | -18.50% | -34.51% |
| 5 Years | %th49.00 | -81.14% | -93.35% |
FAQs
Does Heron Therapeuti (HRTX) outperform the market?
No,
over the last 12 months HRTX made -25.93%, while its related Sector, the SPDR S&P Biotech (XBI) made -9.11%.
Over the last 3 months HRTX made 24.29%, while XBI made 21.37%.
Performance Comparison HRTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
HRTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.9% | 0% | 31.6% | -39% |
| US NASDAQ 100 | QQQ | 0.4% | -0.4% | 30% | -38% |
| German DAX 40 | DAX | -0.9% | 3.6% | 18.9% | -56% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.2% | 0% | 27.9% | -48% |
| Hongkong Hang Seng | HSI | 1.4% | 0.7% | 11.2% | -65% |
| India NIFTY 50 | INDA | 1.7% | 3% | 31.1% | -25% |
| Brasil Bovespa | EWZ | 1.7% | -2.1% | 9.6% | -34% |
HRTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.3% | 0.3% | 27.1% | -50% |
| Consumer Discretionary | XLY | 1.7% | 1.8% | 39.4% | -42% |
| Consumer Staples | XLP | 2.2% | 3.4% | 31.1% | -34% |
| Energy | XLE | -2.2% | -3% | 35.4% | -28% |
| Financial | XLF | 2.2% | 1.1% | 29.1% | -54% |
| Health Care | XLV | 2.7% | 2.7% | 40.6% | -21% |
| Industrial | XLI | 0.8% | 0.7% | 24.7% | -50% |
| Materials | XLB | 0.1% | 0% | 28% | -31% |
| Real Estate | XLRE | 2.1% | 3.9% | 32.7% | -37% |
| Technology | XLK | -0.7% | -3.4% | 27.5% | -36% |
| Utilities | XLU | 2.4% | 2.5% | 29.3% | -48% |
| Aerospace & Defense | XAR | 0.2% | -0% | 13.5% | -74% |
| Biotech | XBI | -0.6% | 3.2% | 45.7% | -17% |
| Homebuilder | XHB | 2.2% | -2.2% | 39.5% | -29% |
| Retail | XRT | 0.9% | 2.2% | 36.3% | -36% |
HRTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.7% | -3.04% | 37.9% | -22% |
| Natural Gas | UNG | 3.2% | 14.2% | 50.8% | -19% |
| Gold | GLD | 2.5% | 4.6% | 13.8% | -65% |
| Silver | SLV | -0.3% | 4.1% | 16% | -44% |
| Copper | CPER | -5.6% | -6.3% | 11.2% | -44% |
HRTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.8% | 2.7% | 35.3% | -23% |
| iShares High Yield Corp. Bond | HYG | 1.6% | 2.5% | 33.2% | -35% |